Harald M. Surowy
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Dominant variants in major spliceosome U4 and U5 small nuclear RNA genes cause neurodevelopmental disorders through splicing disruption.
Journal: Nature genetics
Published: October 02, 2024
Etiological involvement of KCND1 variants in an X-linked neurodevelopmental disorder with variable expressivity.
Journal: American journal of human genetics
Published: November 09, 2023
Delineation of the adult phenotype of Coffin-Siris syndrome in 35 individuals.
Journal: Human genetics
Published: August 28, 2023
Gene expression profiling in porocarcinoma indicates heterogeneous tumor development and substantiates poromas as precursor lesions.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: May 15, 2023
FGF9-Associated Multiple Synostoses Syndrome Type 3 in a Multigenerational Family.
Journal: Genes
Published: February 03, 2023
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study.
Journal: British journal of sports medicine
Published: June 29, 2022
Noncancer-related Secondary Findings in a Cohort of 231 Children With Cancer and Their Parents.
Journal: Journal of pediatric hematology/oncology
Published: November 11, 2021
Correction to: The recurrent missense mutation p.(Arg367Trp) in YARS1 causes a distinct neurodevelopmental phenotype.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: October 18, 2021
Breast cancer risks associated with missense variants in breast cancer susceptibility genes.
Journal: Genome medicine
Published: August 20, 2021
High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma.
Journal: The British journal of dermatology
Published: June 26, 2021
Last Updated: 09/26/2026